Prelude Therapeutics

$22.0M revenue • 120 employees • 175 Innovation Blvd, Wilmington, DE, 19805, United States

Last Updated Jul 8, 2025

Company Overview

Company Name

Prelude Therapeutics

Address

175 Innovation Blvd, Wilmington, DE, 19805, United States

Approx. Annual Revenue

$22.0M

Employees

120

Established

2016

About Prelude Therapeutics

Prelude Therapeutics is a clinical-stage biopharmaceutical company based in Wilmington, Delaware. The company is designing and developing a pipeline of novel, small molecule therapies that target key drivers of cancer cell growth and resistance. Prelude's scientific approach focuses on precision oncology, aiming to translate its discoveries into potential treatments that offer hope to patients with cancer.

More Companies in Delaware

Browse all companies in Delaware →

Frequently Asked Questions about Prelude Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

Kris Vaddi Chief Executive Officer
LinkedIn
Arick Wong Associate Clinical Trial Manager / Senior CRA
LinkedIn
Jaselle Maudlin Clinical Trial Manager
LinkedIn